Carregant...
Anti-Tumor Activity and Pharmacokinetics of AP25-Fc Fusion Protein
AP25 is an anti-tumor peptide with a high affinity for integrins. It exerts its anti-tumor activity by inhibiting angiogenesis and by directly inhibiting the growth of tumor cells. Its half-life time in vivo is only about 50 minutes, which limits its clinical application. In order to prolong the hal...
Guardat en:
| Publicat a: | Int J Med Sci |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Ivyspring International Publisher
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6643120/ https://ncbi.nlm.nih.gov/pubmed/31341417 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.34365 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|